Dose relationship between oral glucocorticoids and tumor necrosis factor inhibitors and the risk of hospitalized infectious events among patients with rheumatoid arthritis

por Schenfeld, Jennifer, Iles, Jan, Trivedi, Mona, Accortt, Neil A.
Publicado 2017

A retrospective cohort study to evaluate the development of comorbidities, including psychiatric comorbidities, among a pediatric psoriasis population

por Paller, Amy S., Schenfeld, Jennifer, Accortt, Neil A., Kricorian, Gregory
Publicado 2019

Changes in Healthcare Utilization After Etanercept Initiation in Patients with Rheumatoid Arthritis: A Retrospective Claims Analysis

por Accortt, Neil A., Schenfeld, Jennifer, Chang, Eunice, Papoyan, Elya, Broder, Michael S.
Publicado 2017

Subsequent Cardiovascular Events Among Patients With Rheumatoid Arthritis, Psoriatic Arthritis, or Psoriasis: Patterns of Disease‐Modifying Antirheumatic Drug Treatment

por Sparks, Jeffrey A., Lesperance, Tamara, Accortt, Neil A., Solomon, Daniel H.
Publicado 2019

Retrospective analysis to describe associations between tumor necrosis factor alpha inhibitors and COPD-related hospitalizations

por Accortt, Neil A, Chung, James B, Bonafede, Machaon, Limone, Brendan L, Mannino, David M
Publicado 2017

Clinical and treatment characteristics of patients treated with the first therapeutic oncology biosimilars bevacizumab-awwb and trastuzumab-anns in the US

por Jin, Ran, Mahtani, Reshma L., Accortt, Neil, Lawrence, Tatiana, Sandschafer, Darcie, Loaiza-Bonilla, Arturo
Publicado 2021

Real-world outcomes among patients with metastatic colorectal cancer treated first line with a bevacizumab biosimilar (bevacizumab-awwb)

por Jin, Ran, Ogbomo, Adesuwa S., Accortt, Neil A., Lal, Lincy S., Bishi, Geetanjali, Sandschafer, Darcie, Goldschmidt, Jerome H.
Publicado 2023

Impact of Sustained Remission on the Risk of Serious Infection in Patients With Rheumatoid Arthritis

por Accortt, Neil A., Lesperance, Tamara, Liu, Mei, Rebello, Sabrina, Trivedi, Mona, Li, Youfu, Curtis, Jeffrey R.
Publicado 2018

Models solely using claims-based administrative data are poor predictors of rheumatoid arthritis disease activity

por Sauer, Brian C., Teng, Chia-Chen, Accortt, Neil A., Burningham, Zachary, Collier, David, Trivedi, Mona, Cannon, Grant W.
Publicado 2017

Empirical evidence of disease activity thresholds used to indicate need for major therapeutic change in US veterans with rheumatoid arthritis

por Sauer, Brian C., Chen, Wei, Xu, Yizhe, Shen, Jincheng, Accortt, Neil A., Collier, David H., Cannon, Grant W.
Publicado 2020

Maintenance of Sustained Low Disease Activity or Remission in Patients With Rheumatoid Arthritis Treated With Etanercept Monotherapy: Results from the Corrona Registry

por Pappas, Dimitrios A., Shan, Ying, Lesperance, Tamara, Kricorian, Greg, Karis, Elaine, Rebello, Sabrina, Hua, Winnie, Accortt, Neil A., Stryker, Scott
Publicado 2020

Persistence on biologic DMARD monotherapy after achieving rheumatoid arthritis disease control on combination therapy: retrospective analysis of corrona registry data

por Pappas, Dimitrios A., Litman, Heather J., Lesperance, Tamara, Kricorian, Greg, Karis, Elaine, Rebello, Sabrina, Hua, Winnie, Accortt, Neil A., Stryker, Scott
Publicado 2020

Incidence of Serious Infections and Design of Utilization and Safety Studies for Biologic and Biosimilar Surveillance

por Zhang, Jie, Sridhar, Gayathri, Barr, Charles E., Eichelberger, Bernadette, Lockhart, Catherine M., Marshall, James, Clewell, Jerry, Accortt, Neil A., Curtis, Jeffrey R., Holmes, Cynthia, McMahill-Walraven, Cheryl N., Brown, Jeffrey S., Haynes, Kevin
Publicado 2020